Medical Radiology and Radiation Safety. 2026. Vol. 71. № 1
DOI:10.33266/1024-6177-2026-71-1-5-13
D.A. Kiseleva1, S.V. An’kov1, N.A. Zhukova1, M.S. Borisova1,
K.S. Bogatisheva1, T.G. Tolstikova1, M.A. Melchenco1, 2, O.I. Yarovaya1, 2
Radioprotective Effect of Ursolic Acid and Arabinogalactan Compositions in CD-1 Mice after a Single X-Ray Irradiation
1 N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Novosibirsk, Russia
2 Novosibirsk State University, Novosibirsk, Russia
Contact person: D.A. Kiseleva, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: Experimental evaluation of radioprotective effects of ursolic acid (UA) and arabinogalactan (AG) compositions in CD-1 mice after a single sub-lethal X-ray irradiation.
Material and methods: The study was conducted on outbred male CD-1 mice weighing 25–30 g. Single total irradiation was performed on X-RAD 320 X-ray at a dose of 5 Gy. Test substances and their compositions in different ratios were administered for two weeks before and four weeks after irradiation. The severity of radiation damage and treatment effects were assessed in dynamics by survival rate, body weight, hematological parameters of blood, histological examination of thymus, heart, liver, spleen, kidneys.
Results: After irradiation with a dose of 5 Gy, the mortality rate of animals in the NC, AG100, AG200, UA:AG100:100, UA:AG50:200, UA:AG100:400 groups were 50 %, in the UA100 group – 40 %, and in the UA:AG100:200 – 30 %. In addition, on the 28th day after irradiation, partial recovery of hematological parameters relative to intact control was observed in the groups UA50, UA100, AG100, AG200, UA:AG100:100, UA:AG50:100, UA:AG100:400. Application of the UA:AG100:200 composition contributed to a statistically significant recovery of leukocytes, erythrocytes and hemoglobin number from the 14th to the 28th day after irradiation in comparison with the negative control group, as well as the recovery on the 28th day after irradiation of all studied hematological blood parameters to the values of intact control. In irradiated animals that received UA individually and in combination with AG, positive dynamics of reparative processes were noted, which were manifested to a greater extent in liver and kidneys.
Conclusion: The inclusion of UА in a composition with AG at a dose of 100:200 mg/kg led to a decrease in the toxic effects of X-ray radiation on CD-1 mice body, namely, positive dynamics of hematological parameters of blood, reparative processes in liver and kidneys, as well as an increase in animal survival of up to 70 % compared with negative controls, which indicates the prospects for further studies of UA compositions effects in comparison with a registered radioprotective drug as a positive control against exposure to ionizing radiation.
Keywords: ursolic acid, arabinogalactan, radioprotective properties, X-ray exposure, mice
For citation: Kiseleva DA, An’kov SV, Zhukova NA, Borisova MS, Bogatisheva KS, Tolstikova TG, Melchenco MA, Yarovaya OI. Radioprotective Effect of Ursolic Acid and Arabinogalactan Compositions in CD-1 Mice after a Single X-Ray Irradiation. Medical Radiology and Radiation Safety. 2026;71(1):5–13. (In Russian). DOI:10.33266/1024-6177-2026-71-1-5-13
References
1. Montay-Gruel P., Meziani L., Yakkala C., Vozenin M.C. Expanding the Therapeutic Index of Radiation Therapy by Normal Tissue Protection. Br J Radiol. 2019;92;1093:20180008. Doi: 10.1259/bjr.20180008.
2. Maier P., Wenz F., Herskind C. Radioprotection of Normal Tissue Cells. Strahlenther Onkol. 2014;190:745-752. Doi: 10.1007/s00066-014-0637-x.
3. Васин М.В. Препарат Б-190 (индралин) в свете истории формирования представлений о механизме действия радиопротекторов // Радиационная биология. Радиоэкология. 2020. T.60. C. 378-395 [Vasin M.V. Drug B-190 (Indralin) in Light of the History of the Formation of Ideas about the Mechanism of Action of Radioprotectors. Radiatsionnaya biologiya. Radioekologiya = Radiation Biology. Radioecology. 2020;60:378-395 (In Russ.)]. Doi: 10.31857/S0869803120040128.
4. Dale D.C., Crawford J., Klippel Z., Reiner M., Osslund T., Fan E., Morrow P.K., Allcott K., Lyman G.H. A Systematic Literature Review of The Efficacy, Effectiveness, and Safety of Filgrastim. Support Care Cancer. 2018;26;1:7-20. Doi: 10.1007/s00520-017-3854-x.
5. Lee M., Yee J., Kim J.Y., Kim J.Y., An S.H., Lee K.E., Gwak H.S. Risk Factors for Neutropenia and Febrile Neutropenia Following Prophylactic Pegfilgrastim. Asia Pac J Clin Oncol. 2019;15;4:231-237. Doi: 10.1111/ajco.13152.
6. Kiseleva D.A., An’Kov S.V., Tolstikova T.G. Ursolic Acid: Sources, Synthesis, Properties, Modifications, Application. Russ J Bioorg Chem. 2025;51;2:508-532. Doi: 10.1134/S1068162024605974.
7. Liu Z., Jiao Y., Wang Y., Zhou C., Zhang Z. Polysaccharides-Based Nanoparticles as Drug Delivery Systems. Adv. Drug Deliv. 2008;60;15:1650-1662. Doi: 10.1016/j.addr.2008.09.001.
8. Медведева Е.Н., Бабкин В.А., Остроухова Л.А. Арабиногалактан лиственницы – свойства и перспективы использования (обзор) // Химия растительного сырья. 2003. №1. С. 27-37 [Medvedeva Ye.N., Babkin V.A., Ostroukhova L.A. Larch Arabinogalactan – Properties and Prospects for Use (Review). Khimiya Rastitel’nogo Syr’ya = Chemistry of Plant Raw Materials. 2003;1:27-37 (In Russ.)].
9. Kong R., Zhu X., Meteleva E.S., Polyakov N.E., Khvostov M.V., Baev D.S., Tolstikova T.G., Dushkin A.V., Su W. Atorvastatin Calcium Inclusion Complexation with Polysaccharide Arabinogalactan and Saponin Disodium Glycyrrhizate for Increasing of Solubility and Bioavailability. Drug Deliv Transl Res. 2018;8;5:1200-1213. Doi: 10.1007/s13346-018-0565-x.
10. Борисов С.А., Хвостов М.В., Толстикова Т.Г., Душкин А.В., Чистяченко Ю.С. Фармакодинамические исследования комплекса включения полисахарида лиственницы арабиногалактана с напроксеном // Сибирский научный медицинский журнал. 2017. Т.37. №4. С. 19-25 [Borisov S.A., Khvostov M.V., Tolstikova T.G., Dushkin A.V., Chistyachenko Yu.S. Pharmacodynamic Studies of the Inclusion Complex of Larch Polysaccharide Arabinogalactan with Naproxen. Sibirskiy Nauchnyy Meditsinskiy Zhurnal = The Siberian Scientific Medical Journal. 2017;37;4:19-25 (In Russ.)].
11. Khvostov M.V., Borisov S.A., Tolstikova T.G., Dushkin A.V., Tsyrenova B.D., Chistyachenko Y.S., Polyakov N.E., Dultseva G.G., Onischuk A.A., An’kov S.V. Supramolecular Complex of Ibuprofen with Larch Polysaccharide Arabinogalactan: Studies on Bioavailability and Pharmacokinetics. Eur J Drug Metab Pharmacokinet. 2017;42;3:431-440. Doi: 10.1007/s13318-016-0357-y.
12. Nguyen H.N., Ullevig S.L., Short J.D., Wang L., Ahn Y.J., Asmis R. Ursolic Acid and Related Analogues: Triterpenoids with Broad Health Benefits. Antioxidants (Basel). 2021;10;8:1161. Doi: 10.3390/antiox10081161.
13. Macià I Garau M., Lucas Calduch A., López EC. Radiobiology of the Acute Radiation Syndrome. Rep Pract Oncol Radiother. 2011;16;4:123-30. Doi: 10.1016/j.rpor.2011.06.001.
14. Horie K., Namiki K., Kinoshita K., Miyauchi M., Ishikawa T., Hayama M., Maruyama Y., Hagiwara N., Miyao T., Murata S., Kobayashi T.J., Akiyama N., Akiyama T. Acute Irradiation Causes a Long-Term Disturbance in the Heterogeneity and Gene Expression Profile of Medullary Thymic Epithelial Cells. Front Immunol. 2023;14:1186154. Doi: 10.3389/fimmu.2023.1186154.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The work was supported by the Russian Science Foundation (project No. 25-25-00119).
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.11.2025. Accepted for publication: 25.12.2025.